Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02504736Completed

Colesevelam, Lipids And Sugars, South Asian Canadian Trial

Role: lead

NCT03090542Not ApplicableCompleted

GPur- Luminating Oral Cholesterol Kinetics Pilot Study

Role: lead

NCT01733160Completed

Stroke Prevention and Rhythm Interventions in Atrial Fibrillation

Role: lead

NCT00950703Completed

Primary Care Audit of Global Risk Management

Role: lead

NCT00485121Not ApplicableCompleted

Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis

Role: lead

All 5 trials loaded